Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Michael Marietta"'
Autor:
Yiqing Shirley Butler-Xu, MD, Michael Marietta, MD, Amir Zahra, DO, Mindi TenNapel, MBA, PhD, Melissa Mitchell, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 4, Iss 2, Pp 261-267 (2019)
Purpose: Hypofractionated radiation therapy (HFRT) remains underused, despite multiple randomized trials showing the equivalence of HFRT to conventional fractionated radiation therapy (CFRT). We sought to retrospectively review the relationship betwe
Externí odkaz:
https://doaj.org/article/8167103a299343d499e71d760f34482c
Publikováno v:
Journal of Gastrointestinal Oncology. 13:2922-2937
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7098059077f813cc6906fd5cf5441c6
https://doi.org/10.21037/jgo-22-542
https://doi.org/10.21037/jgo-22-542
Autor:
John D. Carmichael, Eric L. Chang, Vedang Uttarwar, Michael Marietta, Marisa C. Penn, Douglass W. Tucker, Cheng Yu, Gabriel Zada, Andrew Brunswick, Angad S. Gogia
Publikováno v:
World Neurosurgery. 143:e60-e69
In patients with residual or recurrent nonfunctioning pituitary adenomas (NFPAs) after transsphenoidal resection, both GammaKnife (GKRS) and CyberKnife (CKRS) stereotactic radiosurgery (SRS) are viable treatment options.We report a retrospective sing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::870d6aff661004a75602ccf35ed9dd6b
https://doi.org/10.1016/j.wneu.2020.06.191
https://doi.org/10.1016/j.wneu.2020.06.191
Publikováno v:
Advances in Radiation Oncology
Advances in Radiation Oncology, Vol 4, Iss 2, Pp 261-267 (2019)
Advances in Radiation Oncology, Vol 4, Iss 2, Pp 261-267 (2019)
Purpose: Hypofractionated radiation therapy (HFRT) remains underused, despite multiple randomized trials showing the equivalence of HFRT to conventional fractionated radiation therapy (CFRT). We sought to retrospectively review the relationship betwe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94ecf25b755a6a16b13ccc248228f32a
http://europepmc.org/articles/PMC6460101
http://europepmc.org/articles/PMC6460101
Autor:
Gabriel Zada, Eric L. Chang, Sherwin Tavakol, Steven L. Giannotta, Ben A. Strickland, Cheng Yu, Anna Jackanich, Michael Marietta, Kristine Ravina
Publikováno v:
Operative neurosurgery (Hagerstown, Md.). 18(6)
Background Medical management is the first line of treatment for trigeminal neuralgia (TN). Patients with medically refractory TN may undergo a variety of invasive surgical interventions with varying success rates. Management of TN refractory to both
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8aa97816a5a089536d3107ec97d6a99c
https://pubmed.ncbi.nlm.nih.gov/31620790
https://pubmed.ncbi.nlm.nih.gov/31620790